SEDECAL SA recalled one Mobile X-ray system on June 10, 2025, due to a lack of water resistance. Improper cleaning can lead to serious hazards. Users must stop using the device immediately and follow the manufacturer’s instructions.
Sedecal sent an email to its consignees to remind the users that the equipment is not water-resistant and must be cleaned strictly according to the instructions in the manual, clearly outlining the possible consequences of improper cleaning.
Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact SEDECAL SA or your healthcare provider for instructions. Notification method: E-Mail
The recalled product is the SM_40HF_BDC3 Mobile X-ray system, identified by model UDI/DI 08436046001510 and serial number G41213. It was distributed in California, Illinois, and New Jersey.
The Mobile X-ray system is not water-resistant. Improper cleaning can result in equipment malfunction or failure.
There are no reported incidents or injuries associated with this recall. This recall is preventive based on the potential risks of improper cleaning.
Stop using the Mobile X-ray system immediately. Follow the cleaning instructions provided by the manufacturer. Contact SEDECAL SA or your healthcare provider for further instructions.
For more information, visit the SEDECAL website or contact their customer service via email as per the notification.
Get notified about recalls in categories you care about.
Bristol-Myers Squibb recalled 12,778 vials of Opdualag injection on October 21, 2025. The recall stems from a lack of assurance of sterility. The affected products were distributed nationwide in the United States.
Major Pharmaceuticals recalled Gabapentin Capsules, USP, 100 mg, on October 10, 2025, due to failed impurities specifications. The recall affects several lot numbers distributed nationwide. Consumers must stop using the affected capsules immediately.
Lannett Company, Inc. recalled 46,848 bottles of Niacin Extended-release Tablets on October 10, 2025. The recall follows reports of failed dissolution specifications, which could affect medication effectiveness. Consumers should stop using the product immediately and consult healthcare providers for guidance.